Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released Feb 26, 2020, after the close
10-K filed Feb 27, 2020, 58 days after period end · 0001564590-20-007027
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$78.50M | -$80.01M | -$35.31M | -$18.24M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2019 · filed Feb 27, 2020 · 58 d after period end
+2.6% from the close of Feb 24, 2020 to the close of Feb 28, 2020, the first after the release.